taVNS Treatment for Fibromyalgia

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 3, 2026

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Fibromyalgia

Interventions

DEVICE

Auricular transcutaneous electrical nerve stimulation device

We are investigating whether taVNS can relieve chronic pain symptoms associated with Fibromyalgia.

Trial Locations (1)

Massachusetts General Hospital, Charlestown

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER

NCT04777500 - taVNS Treatment for Fibromyalgia | Biotech Hunter | Biotech Hunter